Wnt2 protein plays a role in the progression of pancreatic cancer promoted by pancreatic stellate cells

Medical Oncology

Volumn 32, Issue 4, 2015, Pages

  Xu, Yong ^a   Li, Hua ^a   Huang, Chongbiao ^a   Zhao, Tiansuo ^a   Zhang, Huan ^a   Zheng, Chen ^a   Ren, He ^a   Hao, Jihui ^a  

^a TIANJIN MEDICAL UNIVERSITY   (China)

Author keywords

Epithelial mesenchymal transition; Pancreatic cancer; Stellate cells; Wnt signal pathway; Wnt2

Indexed keywords

BETA CATENIN; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; WNT2 PROTEIN; WNT2 RECOMBINANT PROTEIN; WNT2 PROTEIN, HUMAN;

ADULT; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CELL ACTIVATION; CELL INVASION; CELL ISOLATION; CELL MIGRATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; LEYDIG CELL; MAJOR CLINICAL STUDY; MALE; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PANCREAS METASTASIS; PANCREATIC STELLATE CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN SECRETION; SUPERNATANT; SURVIVAL TIME; WESTERN BLOTTING; ADENOCARCINOMA; CANCER GRADING; CANCER STAGING; CELL MOTION; CELL PROLIFERATION; DISEASE COURSE; ENZYME IMMUNOASSAY; FLUORESCENT ANTIBODY TECHNIQUE; LYMPH NODE METASTASIS; METABOLISM; MIDDLE AGED; MORTALITY; PANCREAS CARCINOMA; PANCREAS TUMOR; PATHOLOGY; PROGNOSIS; SECONDARY; SURVIVAL RATE; TUMOR CELL CULTURE; TUMOR INVASION;

ADENOCARCINOMA; BETA CATENIN; CARCINOMA, PANCREATIC DUCTAL; CELL MOVEMENT; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOENZYME TECHNIQUES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PANCREATIC NEOPLASMS; PANCREATIC STELLATE CELLS; PROGNOSIS; SURVIVAL RATE; TUMOR CELLS, CULTURED; WNT2 PROTEIN;

EID: 84924070571     PISSN: 13570560     EISSN: 1559131X     Source Type: Journal    
DOI: 10.1007/s12032-015-0513-2     Document Type: Article

References (17)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin. 2011;61(4):212–36.
2. Mario AS, Surabhi D-G, Amanda JR, Hidayatullah GM. Biochemical role of the collagen-rich tumour microenvironment in pancreatic cancer progression. Biochem J. 2012;441(2):541–52.
3. Bachem MG, Schneider E, Groß H, Weidenbach H, Schmid RM, Menke A, et al. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998;115(2):421–32.
4. Froeling FE, Mirza TA, Feakins RM, Seedhar A, Elia G, Hart IR, et al. Organotypic culture model of pancreatic cancer demonstrates that stromal cells modulate E-cadherin, β-catenin, and Ezrin expression in tumor cells. Am J Pathol. 2009;175(2):636–48.
5. Jiang H, Li Q, He C, Li F, Sheng H, Shen X, et al. Activation of the Wnt pathway through Wnt2 promotes metastasis in pancreatic cancer. Am J Cancer Res. 2014;4(5):537.
6. Yu M, Ting DT, Stott SL, Wittner BS, Ozsolak F, Paul S, et al. RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis. Nature. 2012;487(7408):510–3. doi:10.1038/nature11217.
7. Fu L, Zhang C, Zhang L-Y, Dong S-S, Lu L-H, Chen J, et al. Wnt2 secreted by tumour fibroblasts promotes tumour progression in oesophageal cancer by activation of the Wnt/β-catenin signalling pathway. Gut. 2011;60(12):1635–43.
8. Hu Y, Wan R, Yu G, Shen J, Ni J, Yin G, et al. Imbalance of Wnt/Dkk negative feedback promotes persistent activation of pancreatic stellate cells in chronic pancreatitis. PLoS One. 2014;9(4):e95145.
9. Erkan M, Adler G, Apte MV, Bachem MG, Buchholz M, Detlefsen S, et al. Stella TUM: current consensus and discussion on pancreatic stellate cell research. Gut. 2012;61(2):172–8. doi:10.1136/gutjnl-2011-301220.
10. Hwang RF, Moore T, Arumugam T, Ramachandran V, Amos KD, Rivera A, et al. Cancer-associated stromal fibroblasts promote pancreatic tumor progression. Cancer Res. 2008;68(3):918–26.
11. Erkan M, Reiser-Erkan C, Michalski CW, Deucker S, Sauliunaite D, Streit S, et al. Cancer-stellate cell interactions perpetuate the hypoxia-fibrosis cycle in pancreatic ductal adenocarcinoma. Neoplasia. 2009;11(5):497–508.
12. Vonlaufen A, Joshi S, Qu C, Phillips PA, Xu Z, Parker NR, et al. Pancreatic stellate cells: partners in crime with pancreatic cancer cells. Cancer Res. 2008;68(7):2085–93.
13. Froeling FE, Feig C, Chelala C, Dobson R, Mein CE, Tuveson DA, et al. Retinoic acid-induced pancreatic stellate cell quiescence reduces paracrine Wnt–β-catenin signaling to slow tumor progression. Gastroenterology. 2011;141(4):1486–97 e14.
14. Wells JM, Esni F, Boivin GP, Aronow BJ, Stuart W, Combs C, et al. Wnt/β-catenin signaling is required for development of the exocrine pancreas. BMC Dev Biol. 2007;7(1):4.
15. Zhang Y, Morris JP, Yan W, Schofield HK, Gurney A, Simeone DM, et al. Canonical Wnt signaling is required for pancreatic carcinogenesis. Cancer Res. 2013;73(15):4909–22.
16. Morris JP, Wang SC, Hebrok M. KRAS, Hedgehog, Wnt and the twisted developmental biology of pancreatic ductal adenocarcinoma. Nat Rev Cancer. 2010;10(10):683–95.
17. Park J, Song J, He T, Nam S, Lee J, Park W. Overexpression of Wnt-2 in colorectal cancers. Neoplasma. 2008;56(2):119–23.